CellaVision AB (publ) (CEVI.ST)
SEK 222.0
(2.07%)
SEK 222.0
(2.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 463.04 Million SEK | 5.64% |
| 2022 | 438.31 Million SEK | 11.73% |
| 2021 | 392.3 Million SEK | 25.32% |
| 2020 | 313.04 Million SEK | -7.04% |
| 2019 | 336.73 Million SEK | 24.32% |
| 2018 | 270.86 Million SEK | 21.34% |
| 2017 | 223.22 Million SEK | 18.15% |
| 2016 | 188.93 Million SEK | 8.44% |
| 2015 | 174.23 Million SEK | 20.08% |
| 2014 | 145.1 Million SEK | 28.84% |
| 2013 | 112.62 Million SEK | 2.34% |
| 2012 | 110.05 Million SEK | 8.52% |
| 2011 | 101.41 Million SEK | 15.82% |
| 2010 | 87.55 Million SEK | 14.47% |
| 2009 | 76.48 Million SEK | 20.45% |
| 2008 | 63.5 Million SEK | 40.33% |
| 2007 | 45.25 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 124.55 Million SEK | 11.14% |
| 2024 Q1 | 112.06 Million SEK | -17.55% |
| 2024 Q3 | 121.28 Million SEK | -2.62% |
| 2023 Q4 | 135.92 Million SEK | 21.99% |
| 2023 Q2 | 118.83 Million SEK | 22.69% |
| 2023 FY | 463.04 Million SEK | 5.64% |
| 2023 Q1 | 96.86 Million SEK | -4.71% |
| 2023 Q3 | 111.42 Million SEK | -6.23% |
| 2022 Q4 | 101.64 Million SEK | 5.43% |
| 2022 FY | 438.31 Million SEK | 11.73% |
| 2022 Q1 | 115.62 Million SEK | 1.01% |
| 2022 Q2 | 124.62 Million SEK | 7.78% |
| 2022 Q3 | 96.41 Million SEK | -22.64% |
| 2021 Q2 | 93.57 Million SEK | 0.63% |
| 2021 Q4 | 114.47 Million SEK | 25.42% |
| 2021 Q1 | 92.98 Million SEK | 8.33% |
| 2021 FY | 392.3 Million SEK | 25.32% |
| 2021 Q3 | 91.27 Million SEK | -2.46% |
| 2020 Q1 | 92.31 Million SEK | -7.56% |
| 2020 Q4 | 85.83 Million SEK | 50.53% |
| 2020 FY | 313.04 Million SEK | -7.04% |
| 2020 Q3 | 57.02 Million SEK | -26.77% |
| 2020 Q2 | 77.87 Million SEK | -15.64% |
| 2019 Q2 | 87.09 Million SEK | 13.07% |
| 2019 Q3 | 72.75 Million SEK | -16.46% |
| 2019 Q1 | 77.02 Million SEK | -6.01% |
| 2019 FY | 336.73 Million SEK | 24.32% |
| 2019 Q4 | 99.85 Million SEK | 37.26% |
| 2018 Q1 | 57.72 Million SEK | 4.19% |
| 2018 FY | 270.86 Million SEK | 21.34% |
| 2018 Q4 | 81.95 Million SEK | 31.75% |
| 2018 Q3 | 62.2 Million SEK | -9.82% |
| 2018 Q2 | 68.98 Million SEK | 19.5% |
| 2017 Q4 | 55.4 Million SEK | 28.35% |
| 2017 Q1 | 68 Million SEK | 28.86% |
| 2017 Q2 | 56.64 Million SEK | -16.7% |
| 2017 Q3 | 43.16 Million SEK | -23.8% |
| 2017 FY | 223.22 Million SEK | 18.15% |
| 2016 Q4 | 52.77 Million SEK | 10.25% |
| 2016 FY | 188.93 Million SEK | 8.44% |
| 2016 Q2 | 47.39 Million SEK | 15.87% |
| 2016 Q3 | 47.86 Million SEK | 1.0% |
| 2016 Q1 | 40.9 Million SEK | -11.9% |
| 2015 Q4 | 46.42 Million SEK | -15.32% |
| 2015 Q3 | 54.82 Million SEK | 49.51% |
| 2015 Q2 | 36.67 Million SEK | 1.01% |
| 2015 FY | 174.23 Million SEK | 20.08% |
| 2015 Q1 | 36.3 Million SEK | -28.07% |
| 2014 Q1 | 27.99 Million SEK | -29.65% |
| 2014 FY | 145.1 Million SEK | 28.84% |
| 2014 Q4 | 50.47 Million SEK | 66.25% |
| 2014 Q3 | 30.36 Million SEK | -16.3% |
| 2014 Q2 | 36.27 Million SEK | 29.59% |
| 2013 Q2 | 23.39 Million SEK | 6.46% |
| 2013 Q3 | 27.46 Million SEK | 17.38% |
| 2013 Q4 | 39.78 Million SEK | 44.86% |
| 2013 FY | 112.62 Million SEK | 2.34% |
| 2013 Q1 | 21.97 Million SEK | -30.66% |
| 2012 Q4 | 31.69 Million SEK | 40.3% |
| 2012 Q1 | 27.07 Million SEK | -16.04% |
| 2012 Q2 | 28.69 Million SEK | 6.01% |
| 2012 Q3 | 22.59 Million SEK | -21.28% |
| 2012 FY | 110.05 Million SEK | 8.52% |
| 2011 Q3 | 22.63 Million SEK | -12.03% |
| 2011 FY | 101.41 Million SEK | 15.82% |
| 2011 Q4 | 32.24 Million SEK | 42.46% |
| 2011 Q1 | 20.8 Million SEK | -27.95% |
| 2011 Q2 | 25.72 Million SEK | 23.63% |
| 2010 Q2 | 26.78 Million SEK | 90.97% |
| 2010 Q3 | 17.86 Million SEK | -33.28% |
| 2010 Q1 | 14.02 Million SEK | -5.51% |
| 2010 FY | 87.55 Million SEK | 14.47% |
| 2010 Q4 | 28.88 Million SEK | 61.64% |
| 2009 Q3 | 22.72 Million SEK | 35.15% |
| 2009 Q1 | 14.11 Million SEK | -4.12% |
| 2009 Q4 | 14.84 Million SEK | -34.69% |
| 2009 Q2 | 16.81 Million SEK | 19.1% |
| 2009 FY | 76.48 Million SEK | 20.45% |
| 2008 FY | 63.5 Million SEK | 40.33% |
| 2008 Q2 | 13.93 Million SEK | 0.0% |
| 2008 Q3 | 18.87 Million SEK | 35.46% |
| 2008 Q4 | 14.72 Million SEK | -22.0% |
| 2007 FY | 45.25 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acarix AB (publ) | 5.29 Million SEK | -8641.571% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -54.039% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -54.039% |
| Arcoma AB | 11.07 Million SEK | -4082.468% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | -230.788% |
| BICO Group AB (publ) | 1.83 Billion SEK | 74.706% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | -85.429% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | -15350.15% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | 1729.618% |
| C-Rad AB (publ) | 66.01 Million SEK | -601.418% |
| Duearity AB (publ) | -4.17 Million SEK | 11182.839% |
| Dignitana AB (publ) | 58.97 Million SEK | -685.201% |
| Episurf Medical AB (publ) | -41.8 Million SEK | 1207.754% |
| Getinge AB (publ) | 13.43 Billion SEK | 96.552% |
| Scandinavian Real Heart AB (Publ) | -50.21 Million SEK | 1022.074% |
| Iconovo AB (publ) | 17.57 Million SEK | -2534.259% |
| Integrum AB (publ) | 690.56 Thousand SEK | -66952.777% |
| Luxbright AB (publ) | -2.79 Million SEK | 16655.65% |
| Mentice AB (publ) | 236.38 Million SEK | -95.888% |
| OssDsign AB (publ) | 83.64 Million SEK | -453.579% |
| Paxman AB (publ) | 12.61 Million SEK | -3569.686% |
| Promimic AB (publ) | 38.51 Million SEK | -1102.235% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 1012.342% |
| SciBase Holding AB (publ) | 16.03 Million SEK | -2787.329% |
| ScandiDos AB (publ) | 47.55 Million SEK | -873.696% |
| Sectra AB (publ) | 557.55 Million SEK | 16.951% |
| Sedana Medical AB (publ) | 108.98 Million SEK | -324.882% |
| Senzime AB (publ) | 8.33 Million SEK | -5452.716% |
| SpectraCure AB (publ) | -9.22 Million SEK | 5120.503% |
| Stille AB | 132.17 Million SEK | -250.335% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 76.59% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | -11.064% |